Abstract
Uterine sarcomas are heterogeneous group of tumours comprising 1% of gynaecological malignancies. There is lack of concences on optimal treatment of uterine sarcomas. This is because of lack of randomised controlled trials due to rarity of these tumours. Surgical management without spill remains the standard primary treatment. Most of the times uterine sarcomas are diagnosed postoperatively from histopathology report of either myomectomy or hysterectomy. This retrospective study analysed the clinico pathological characteristics, prognostic factors, treatment details and survival outcome of different types of uterine sarcomas.
Materials and methods
This is a retrospective analysis of 59 patients of uterine sarcomas. All patients underwent surgery. Adjuvant chemotherapy or radiation treatment were given according to histopathological report and FIGO stage. Patients were followed up every three months for first two years and then every six months. Disease free survival (DFS) and Overall survival (OS) were calculated.
Statistical analysis
The data were summarized using descriptive statistics as mean, percent and range. Survival probabilities were estimated using Kaplan–Meier method and the significance of difference between the survival curves were calculate using log-rank test.
Results
Uterine sarcomas are rare and aggressive tumours of uterus. Majority of these tumours present in early stage. Surgery remains the main treatment modality. Role of adjuvant radiation treatment remains controversial. Tumour stage is the most important prognostic factor.
Similar content being viewed by others
References
Prat J, Mbatani N. Uterine sarcomas. Int J Gynaecol Obstet. 2015;131(Suppl 2):S105-10. https://doi.org/10.1016/j.ijgo.2015.06.006.
Chern JY, Boyd LR, Blank SV. Uterine sarcomas: the latest approaches for these rare but potentially deadly tumours. Oncology. 2017;31:229–36.
Sharma DN, Rath GK, Kumar S, et al. Clinical outcome of patients with uterine sarcomas. J Cancer Res Ther. 2011;7:270–4.
D’Angelo E, Prat J. Uterine sarcomas: a review. Gynecol Oncol. 2010;116:131–9.
Yamada SD, Burger RA, Brewster WR, et al. Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcomas of the uterus. Cancer. 2000;88:2782–6.
Prat J. FIGOstagingfor uterine sarcomas. Int J Gynaecol Obstet. 2009;104:177–8.
Giuntoli RL, Metzinger DS, DiMarco CS, et al. Retrospective review of 208 patients with Leiomyosarcoma of the uterus: Prognostic indicators, surgical management, and adjuvant therapy. Gynecol Oncol. 2003;89:460–9.
Sagae S, Yamashita K, Ishioka S, et al. Preoperative diagnosis and treatment results in 106 patients with uterine sarcoma in Hokkaido, Japan. Oncology. 2004;67(33–9):9.
Wais M, Tepperman E, Bernardini MQ, et al. A multicentre retrospective review of clinical characteristics of uterine sarcoma. J Obstet Gynaecol Can. 2017;39:652–8.
Benson C, Miah AB. Uterine sarcoma - current perspectives. Int J Womens Health. 2017;9:597–606. https://doi.org/10.2147/IJWH.S117754.
Zappacosta R, Fanfani F, Zappacosta B, et al. Uterine Sarcomas An Updated Overview Part 1 Smooth Muscle Tumors. In: NaveedShahzad Hafiz, editor., et al., Neoplasm. InTech; 2018. https://doi.org/10.5772/intechopen.76772.
Gao Y, Meng H, Zhang Y, et al. Retrospective analysis of 80 cases with uterine carcinosarcoma, leiomyosarcoma and endometrial stromal sarcoma in China, 1988–2007. Int J Clin Exp Pathol. 2014;7(4):1616–24.
Sagae S, Yamashita K, Ishioka S, et al. Preoperative diagnosis and treatment results in 106 patients with uterine sarcoma in Hokkaido, Japan. Oncology. 2004;67:33–9.
Kho KA, Lin K, Hechanov M, et al. Risk of occult uterine sarcoma in women undergoing hysterectomy for benign indications. Obstet Gynecol. 2016;127:468–73.
Mbatani N, Olawaiye AB, Prat J. Uterine Sarcomas FIGO Cancer report. Int J Gynecol Obstet. 2018;143(Suppl. 2):51–8.
Tropé CG, Abeler VM, Kristensen GB. Diagnosis and treatment of sarcoma of the uterus. A review 2012. Acta Oncol. 2012;51:694–705.
Hosh M, Antar S, Nazzal A, et al. Uterine sarcoma analysis of 13,089 cases based on surveillance, epidemiology, and end results database. Int J Gynecol Cancer. 2016;26:1098–104.
Noventa M, Gizzo S, Conte L, et al. Fertility sparing surgery in young women affected by endometrial stromal sarcoma: an oncologic dilemma or a reliable option? Review of literature starting from a peculiar case. Onco Targets Ther. 2014;8:29–35.
Nam JH. Surgical treatment of uterine sarcoma. Best Pract Res Clin Obstet Gynaecol. 2011;25(751–60):22.
Kapp DS, Shin JY, Chan JK. Chan, Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy. Cancer. 2008;112:82030.
Amant F, De Knijf A, Van Calster B, et al. Clinical study investigating the role of lymphadenectomy, surgical castration and adjuvant hormonal treatment in endometrial stromal sarcoma. Br J Cancer. 2007;97:1194–9.
Benito V, Lubrano A, Arencibia O, et al. Clinicopathologic analysis of uterine sarcomas from a single institution in the Canary Islands. Int J Gynaecol Obstet. 2009;107:44–9.
Potikul C, Tangjitgamol S, Khunnarong J, et al. Uterine sarcoma: clinical presentation, treatment and survival outcomes in Thailand. Asian Pac J Cancer Prev. 2016;17:1759–67.
Amant F, Coosemans A, Debiec-Rychter M, et al. Clinical management of uterine sarcomas. Lancet Oncol. 2009;10:1188–98.
Meseci Elif. Mehmet Murat Naki (2019) Prognostic factors survival outcomes and surgical practices when dealing with uterine sarcomas: 8 years’ clinical experience. J Turk Ger Gynecol Assoc. 2019;20:154–64.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Authors declare that they have no conflict of interest.
Ethical approval
This study has approval from the IRBðics committee.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
S. Suchetha: Additional professor. T. Vijayashanti: Seniour fellow. Rema. P Additional professor, J. Sivaranjith: Assistant Professor. Aswin kumar: Additional Professor. K. M. Jagathnath Krishna: Additional Professor. Francis. V. James: Professor.
Rights and permissions
About this article
Cite this article
Suchetha, S., Vijayashanti, T., Rema, P. et al. Uterine Sarcoma: Retrospective Study From A Single institute. J Obstet Gynecol India 72 (Suppl 1), 306–312 (2022). https://doi.org/10.1007/s13224-021-01612-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13224-021-01612-9